Information BAY-985 is a potent and highly selectiveTBK1/IKKεinhibitor. BAY-985 shows high potency towardTBK1(IC50 = 2 nM, low ATP assay; 30 nM, high ATP assay) andIKKε(IC50 = 2 nM), as well as high potency in the mechanistic pIRF3 assay (IC50 = 74 nM), and an antiproliferative effect on SK-MEL-2 cells (IC50 = 900 nM). Targets TBK1 (in low ATP assay); IKKε (Cell-free assay); TBK1 (in high ATP assay); pIRF3 (Cell-free assay) 2 nM ;2 nM; 30 nM; 74 nM In vitro BAY-985 is a potent and highly selective TBK1/IKKε inhibitor that inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2. In vivo BAY-985 shows only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model. Cell Research(from reference) Cell lines：ACHN, SK-MEL-2, MDA-MB231 cells Concentrations：100 nM Incubation Time：96 h